Sucampo Pharmaceuticals, Inc. 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Sep 15, 2014
Insider Transaction Report
Form 4
Transactions
- Award
Employee Stock Option (Right to Buy)
2014-09-11+25,000→ 235,650 totalExercise: $6.75From: 2018-09-11Exp: 2024-09-11→ Class A Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Performance Conditions for accelerated vesting: One third of the Total Award may vest prior to the Vesting Date each time the Compensation Committee approves management's recommendation that certain pre-determined targets have been achieved in one of the three categories of strategic objectives of the Company.